Scanned by

    Norton

    Norton™ Safe Web

    Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain

    Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain

    28:19 |
    Download Here

    You Might Also Like:

    Introducing the Oncology Data Advisor® Fellows Forum: Samuel Kareff, MD, MPH

    Introducing the Oncology Data Advisor® Fellows Forum: Samuel Kareff, MD, MPH

    4:01 |
    World Lung Cancer Day: A Glimpse Into Hope for the Future

    World Lung Cancer Day: A Glimpse Into Hope for the Future

    15:09 |
    Exciting Directions for Oncology Data Advisor: Live From ASCO With Thomas Abrams, Editor in Chief

    Exciting Directions for Oncology Data Advisor: Live From ASCO With Thomas Abrams, Editor in Chief

    5:56 |
    Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

    Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

    22:49 |
    The Power of Oncology Collaboration: An Interdisciplinary Conversation With OncData and MedNews Week

    The Power of Oncology Collaboration: An Interdisciplinary Conversation With OncData and MedNews Week

    36:47 |
    Advances in HNSCC: Immunotherapy & Targeted Treatments for Head and Neck Cancer

    Advances in HNSCC: Immunotherapy & Targeted Treatments for Head and Neck Cancer

    9:02 |
    Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

    Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

    9:22 |
    The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO

    The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO

    17:53 |
    Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD

    Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD

    6:39 |
    Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD

    Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD

    4:58 |
    The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu, MD, MBBS

    The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu, MD, MBBS

    10:07 |
    Additional Advances in Immune Thrombocytopenia Research and Clinical Trials

    Additional Advances in Immune Thrombocytopenia Research and Clinical Trials

    9:42 |
    Childhood Cancer Awareness Month: A Primer on Pediatric Cancers With Tristan Knight, MD, FRCPC

    Childhood Cancer Awareness Month: A Primer on Pediatric Cancers With Tristan Knight, MD, FRCPC

    27:43 |
    Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain

    Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain

    28:20 |
    Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNP

    Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNP

    12:22 |
    World Breast Cancer Research Day: Making Strides in Neuropathy Research

    World Breast Cancer Research Day: Making Strides in Neuropathy Research

    30:10 |
    Pain Awareness Month With Nida Khan, MD, and Joseph Kalis, PharmD, BCOP

    Pain Awareness Month With Nida Khan, MD, and Joseph Kalis, PharmD, BCOP

    17:12 |
    Prostate Cancer Awareness Month: Overcoming Disparities With Waqas Haque, MD, MPH

    Prostate Cancer Awareness Month: Overcoming Disparities With Waqas Haque, MD, MPH

    4:54 |
    Linvoseltamab for Relapsed/Refractory Multiple Myeloma: IMS 2023 Results With Madhav Dhodapkar, MD

    Linvoseltamab for Relapsed/Refractory Multiple Myeloma: IMS 2023 Results With Madhav Dhodapkar, MD

    6:17 |
    Validating Oncology Nursing Experience Through ONCC Certification: Tony Ellis, MSEd, CAE, ICE-CCP

    Validating Oncology Nursing Experience Through ONCC Certification: Tony Ellis, MSEd, CAE, ICE-CCP

    4:32 |